First Time Loading...

Hyloris Pharmaceuticals SA
XBRU:HYL

Watchlist Manager
Hyloris Pharmaceuticals SA Logo
Hyloris Pharmaceuticals SA
XBRU:HYL
Watchlist
Price: 11.7 EUR
Updated: May 15, 2024

Wall Street
Price Targets

HYL Price Targets Summary
Hyloris Pharmaceuticals SA

Wall Street analysts forecast HYL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HYL is 21.11 EUR with a low forecast of 18.89 EUR and a high forecast of 23.21 EUR.

Lowest
Price Target
18.89 EUR
61% Upside
Average
Price Target
21.11 EUR
80% Upside
Highest
Price Target
23.21 EUR
98% Upside
Hyloris Pharmaceuticals SA Competitors:
Price Targets
512
Grand Pharmaceutical Group Ltd
55% Upside
600380
Joincare Pharmaceutical Group Industry Co Ltd
13% Upside
MDWD
Mediwound Ltd
63% Upside
4519
Chugai Pharmaceutical Co Ltd
31% Upside
APPH
Apontis Pharma AG
98% Upside
600566
Hubei Jumpcan Pharmaceutical Co Ltd
32% Upside
950
Lee's Pharmaceutical Holdings Ltd
12% Downside
CURA
Curaleaf Holdings Inc
29% Upside

Revenue
Forecast

Revenue Estimate
Hyloris Pharmaceuticals SA

For the last 5 years the compound annual growth rate for Hyloris Pharmaceuticals SA's revenue is 99%. The projected CAGR for the next 3 years is 183%.

99%
Past Growth
183%
Estimated Growth
Estimates Accuracy
-39%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Hyloris Pharmaceuticals SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-41%
Average Miss

Net Income
Forecast

Net Income Estimate
Hyloris Pharmaceuticals SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HYL's stock price target?
Price Target
21.11 EUR

According to Wall Street analysts, the average 1-year price target for HYL is 21.11 EUR with a low forecast of 18.89 EUR and a high forecast of 23.21 EUR.

What is Hyloris Pharmaceuticals SA's Revenue forecast?
Projected CAGR
183%

For the last 5 years the compound annual growth rate for Hyloris Pharmaceuticals SA's revenue is 99%. The projected CAGR for the next 3 years is 183%.